Fat loss
Cagrilintide
Long-acting amylin analogue for once-weekly dosing. Useful on its own; dramatically more useful paired with Semaglutide as the CagriSema combination.
€134.99per vial
Choose an option
1
- Pay with Bitcoin
- Discreet shipping within Germany
- Purity-guaranteed batches
- 14-day refund period if unsatisfied
Delivery & guarantee
Orders typically arrive within 3 weeks.
If your delivery arrives late, you'll receive a discount on your next order.
About
Cagrilintide is the long-acting cousin of pramlintide, which has been on the diabetes market since 2005 for postprandial glucose control. Amylin is co-secreted with insulin and acts through receptors distinct from GLP-1.
Read the full research guideWhy people choose it
- Average 8 to 10% body-weight reduction as monotherapy at 2.4 mg over 26 weeks
- Mechanism distinct from GLP-1, so it adds rather than overlaps when stacked
- Milder GI side effect profile than GLP-1 agonists at equivalent weight-loss steps
- No meaningful glycaemic effect in non-diabetics, so usable as a satiety tool without affecting blood sugar
At a glance
- Experience level
- Advanced
- Administration
- Subcutaneous
Sold for laboratory research only. Not for human consumption. No therapeutic claims are made.
Sign in to view this product
Cagrilintide
Log in or create a free account to see full details and prices.
Don't have an account? Sign up